- Home
- AZ vs AMRN Comparison
AZ vs AMRN Comparison
Compare AZ & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZ
- AMRN
- Stock Information
- Founded
- AZ 2018
- AMRN 1989
- Country
- AZ Canada
- AMRN Ireland
- Employees
- AZ N/A
- AMRN N/A
- Industry
- AZ Industrial Machinery/Components
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AZ Industrials
- AMRN Health Care
- Exchange
- AZ Nasdaq
- AMRN Nasdaq
- Market Cap
- AZ 319.5M
- AMRN 302.0M
- IPO Year
- AZ N/A
- AMRN 1993
- Fundamental
- Price
- AZ $7.25
- AMRN $16.81
- Analyst Decision
- AZ Strong Buy
- AMRN Strong Sell
- Analyst Count
- AZ 1
- AMRN 1
- Target Price
- AZ $20.00
- AMRN $12.00
- AVG Volume (30 Days)
- AZ 427.1K
- AMRN 157.9K
- Earning Date
- AZ 11-13-2025
- AMRN 10-29-2025
- Dividend Yield
- AZ N/A
- AMRN N/A
- EPS Growth
- AZ N/A
- AMRN N/A
- EPS
- AZ N/A
- AMRN N/A
- Revenue
- AZ $7,489,000.00
- AMRN $226,733,000.00
- Revenue This Year
- AZ $1,343,857.60
- AMRN N/A
- Revenue Next Year
- AZ N/A
- AMRN N/A
- P/E Ratio
- AZ N/A
- AMRN N/A
- Revenue Growth
- AZ 19.04
- AMRN N/A
- 52 Week Low
- AZ $4.66
- AMRN $7.08
- 52 Week High
- AZ $12.36
- AMRN $20.90
- Technical
- Relative Strength Index (RSI)
- AZ 46.66
- AMRN 38.22
- Support Level
- AZ $6.41
- AMRN $19.39
- Resistance Level
- AZ $7.70
- AMRN $20.90
- Average True Range (ATR)
- AZ 0.52
- AMRN 1.07
- MACD
- AZ 0.11
- AMRN -0.34
- Stochastic Oscillator
- AZ 68.97
- AMRN 2.62
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.